Applied Molecular Transport Inc. (AMTI): Price and Financial Metrics
GET POWR RATINGS... FREE!
AMTI Stock Price Chart Interactive Chart >
AMTI Price/Volume Stats
| Current price | $3.33 | 52-week high | $52.71 |
| Prev. close | $3.10 | 52-week low | $2.90 |
| Day low | $3.02 | Volume | 152,100 |
| Day high | $3.38 | Avg. volume | 330,357 |
| 50-day MA | $5.23 | Dividend yield | N/A |
| 200-day MA | $14.67 | Market Cap | 128.72M |
Applied Molecular Transport Inc. (AMTI) Company Bio
Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. The company was founded by Tahir Mahmood and Randall J. Mrsny on November 21, 2016 and is headquartered in South San Francisco, CA.
Latest AMTI News From Around the Web
Below are the latest news stories about Applied Molecular Transport Inc that investors may wish to consider to help them evaluate AMTI as an investment opportunity.
Applied Molecular Transport Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateFour top-line data readouts expected in 2022 from ongoing oral AMT-101 Phase 2 trials, as follows FILLMORE monotherapy trial for patients with chronic pouchitis followed by MARKET combination trial with anti-TNFα in ulcerative colitis (UC) in H1 2022LOMBARD monotherapy trial in UC and CASTRO combination trial with anti-TNFα in rheumatoid arthritis (RA) in H2 2022 Phase 1 ongoing for second product candidate, oral AMT-126, with program update in H1 2022 SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022 |
Applied Molecular Transport to Present at SVB Leerink Virtual 11th Annual Global Healthcare ConferenceSOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the SVB Leerink Virtual 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 1:00 p.m. ET. A live webcast will be accessible via the Events page of the Applied Molecular Transport website at |
Applied Molecular Transport Announces Board AppointmentsJohn W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair Helen S. Kim Named Lead Independent Director SOUTH SAN FRANCISCO, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of John W. Smither to its Board of Directors and Chair of its Audit Committee. AMT also announced that current Director, Graham K. Cooper, |
Applied Molecular Transport (NASDAQ:AMTI) Trading Down 3.4%Applied Molecular Transport Inc. (NASDAQ:AMTI)s stock price traded down 3.4% during trading on Tuesday . The company traded as low as $13.29 and last traded at $13.41. 2,387 shares changed hands during trading, a decline of 99% from the average session volume of 439,193 shares. The stock had previously closed at $13.88. Several research analysts [] |
Applied Molecular Transport (NASDAQ:AMTI) Hits New 12-Month Low at $13.99Applied Molecular Transport Inc. (NASDAQ:AMTI)s stock price reached a new 52-week low during trading on Monday . The company traded as low as $13.99 and last traded at $14.25, with a volume of 11000 shares trading hands. The stock had previously closed at $14.42. A number of research analysts have issued reports on the stock. [] |
AMTI Price Returns
| 1-mo | -22.38% |
| 3-mo | -49.32% |
| 6-mo | -80.41% |
| 1-year | -93.05% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -76.18% |
| 2021 | -54.57% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...